Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

D1000000

Dibenzosuberon

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

5-Dibenzosuberon, 10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-on, Dibenzocycloheptadienon

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C15H12O
CAS-Nummer:
1210-35-1
Molekulargewicht:
208.26
Beilstein:
1454355
MDL-Nummer:
MFCD00003587
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329798658
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

nortriptyline, amitriptyline

Hersteller/Markenname

EDQM

Brechungsindex

n20/D 1.6332 (lit.)

bp

148 °C/0.3 mmHg (lit.)

mp (Schmelzpunkt)

32-34 °C (lit.)

Dichte

1.156 g/mL at 25 °C (lit.)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

O=C1c2ccccc2CCc3ccccc13

InChI

1S/C15H12O/c16-15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-8H,9-10H2

InChIKey

BMVWCPGVLSILMU-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

Dieses Produkt wird, wie von der entsprechenden Pharmakopöe spezifiziert und geliefert, angeboten. Alle Informationen zu diesem Produkt, einschließlich SDB und jegliche Produktinformationen, wurden unter der Autorität der entsprechenden Pharmakopöe entwickelt und ausgestellt.
Weitere Informationen und Unterstützung finden Sie auf der Webseite der entsprechenden Pharmakopöe.

Anwendung

Dibenzosuberone EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

Dieses Produkt wird, wie von der entsprechenden Pharmakopöe geliefert, angeboten. Die aktuellen Mengeneinheiten finden Sie im Referenzsubstanzen-Katalog der EDQM.

Sonstige Hinweise

Kann Verkaufsbeschränkungen unterliegen.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

1029002

Amitriptylin -hydrochlorid, United States Pharmacopeia (USP) Reference Standard

1474005

Nortriptylin -hydrochlorid, United States Pharmacopeia (USP) Reference Standard

N1280000

Nortriptylin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard

PHR1384

Amitriptylin-Hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material

Y0000563

Amitriptylin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard

Y0001296

Nortriptylin für die Systemeignung, European Pharmacopoeia (EP) Reference Standard

1029013

Amitriptylin-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

1029024

Amitriptylin-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

PHR1776

5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol, Pharmaceutical Secondary Standard; Certified Reference Material

BP269

Nortriptylin -hydrochlorid, British Pharmacopoeia (BP) Reference Standard

BP016

Amitriptylin -hydrochlorid, British Pharmacopoeia (BP) Reference Standard

BP858

Dibenzosuberon, British Pharmacopoeia (BP) Reference Standard

PHR3216

Nortriptylin-Hydrochlorid, pharmaceutical secondary standard, certified reference material

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

235.4 °F - closed cup

Flammpunkt (°C)

113 °C - closed cup

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Stefan Fischer et al.
Journal of medicinal chemistry, 56(1), 241-253 (2012-12-29)
p38α mitogen-activated protein (MAP) kinase is a main target in drug research concerning inflammatory diseases. Nevertheless, no inhibitor of p38α MAP kinase has been introduced to the market. This might be attributed to the fact that there is no inhibitor
Solveigh C Koeberle et al.
Journal of medicinal chemistry, 55(12), 5868-5877 (2012-06-09)
Synthesis, biological testing, structure-activity relationships (SARs), and selectivity of novel disubstituted dibenzosuberone derivatives as p38 MAP kinase inhibitors are described. Hydrophilic moieties were introduced at the 7-, 8-, and 9-position of the 2-phenylamino-dibenzosuberones, improving physicochemical properties as well as potency.
Sonja Merkas et al.
Molecules (Basel, Switzerland), 10(12), 1429-1437 (2007-11-17)
Novel representatives of the important group of biologically active dibenzosuberone derivatives were prepared: 3,7-dibromo-5-(dimethylaminoethyl- oxyimino)-10,11-dihydro-5H-dibenzo[a,d]cyclohepta-1,4-diene (1), 3,7-dibromo-5-(3- dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (2) and 1,7- dibromo-5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo-[a,d]-cycloheptene (3). These compounds are potential tricyclic antidepressants (TCAs), which are still the most frequently prescribed antidepressants in many
S P Dixon et al.
Pharmeuropa scientific notes, 2005(1), 15-20 (2007-08-11)
An isocratic reversed-phase liquid chromatographic method is described using a hybrid column for the control of synthetic impurities potentially found in amitriptyline hydrochloride. The method has been validated and is capable of controlling impurities to 0.1 per cent.
S Zbaida et al.
Biopharmaceutics & drug disposition, 11(1), 39-51 (1990-01-01)
Reactions of trans-stilbene, cis-stilbene, 5H-dibenzo [a,d] cyclo-heptene 5-one and 5H-dibenz [b,f] azepine (iminostilbene) with Fenton reagent [Fe (II)/H2O2] clearly simulate their hepatic metabolism. Expoxidation on the corresponding ethylenic linkage was found to be a common pathway of these compounds. Epoxides

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.